ELIXINOL WELLNESS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.005 AUD | -16.67% |
|
-16.67% | -58.33% |
| Apr. 18 | Transcript : Elixinol Wellness Limited - Shareholder/Analyst Call | |
| Mar. 28 | Elixinol Wellness Limited completed the acquisition of Ananda Food Pty Ltd from Ecofibre Limited. | CI |
Valuation
| Fiscal Period: December | 2019 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Capitalization 1 | 77.46 | 22.75 | 6.639 | 7.594 | 6.505 |
| Enterprise Value (EV) 1 | 77.46 | 22.75 | 6.639 | 7.594 | 6.505 |
| P/E ratio | -1.15 x | -1.71 x | - | - | -0.5 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 2.85 x | - | 0.94 x | 0.92 x | 0.52 x |
| EV / Revenue | 2.85 x | - | 0.94 x | 0.92 x | 0.52 x |
| EV / EBITDA | -3.38 x | - | -0.78 x | -1.64 x | -1.08 x |
| EV / FCF | -1.14 x | - | -0.81 x | -2.74 x | -1.04 x |
| FCF Yield | -88% | - | -123% | -36.5% | -95.7% |
| Price to Book | 0.9 x | - | - | - | - |
| Nbr of stocks (in thousands) | 137,102 | 315,929 | 316,132 | 632,872 | 1,301,074 |
| Reference price 2 | 0.5650 | 0.0720 | 0.0210 | 0.0120 | 0.005000 |
| Announcement Date | 2/26/20 | 2/25/22 | 2/27/23 | 2/28/24 | - |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Net sales 1 | 27.18 | - | 7.055 | 8.269 | 12.5 |
| EBITDA 1 | -22.9 | - | -8.538 | -4.626 | -6.051 |
| EBIT 1 | -25.35 | - | -9.5 | -5.898 | -6.635 |
| Operating Margin | -93.26% | - | -134.66% | -71.33% | -53.06% |
| Earnings before Tax (EBT) 1 | - | - | - | - | -6.675 |
| Net income 1 | -83.34 | -17.02 | - | - | -6.675 |
| Net margin | -306.6% | - | - | - | -53.38% |
| EPS 2 | -0.4902 | -0.0421 | - | - | -0.0100 |
| Free Cash Flow 1 | -68.17 | - | -8.157 | -2.77 | -6.227 |
| FCF margin | -250.77% | - | -115.62% | -33.5% | -49.79% |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 2/26/20 | 2/25/22 | 2/27/23 | 2/28/24 | - |
1AUD in Million2AUD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - |
| Net Cash position | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow 1 | -68.2 | - | -8.16 | -2.77 | -6.23 |
| ROE (net income / shareholders' equity) | -65.3% | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets 1 | - | - | - | - | - |
| Book Value Per Share | 0.6300 | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - |
| Capex 1 | 9.94 | - | - | - | 0.25 |
| Capex / Sales | 36.58% | - | - | - | 2% |
| Announcement Date | 2/26/20 | 2/25/22 | 2/27/23 | 2/28/24 | - |
1AUD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.005
AUD
Average target price
0.04
AUD
Spread / Average Target
+700.00%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -58.33% | 4.3M | |
| +24.11% | 105B | |
| -4.02% | 39.65B | |
| +26.22% | 35.07B | |
| +14.96% | 20.58B | |
| +10.42% | 18.99B | |
| -3.51% | 8.74B | |
| +6.28% | 8.24B | |
| +15.69% | 7.16B | |
| +26.41% | 5.71B |
- Stock Market
- Equities
- EXL Stock
- Financials Elixinol Wellness Limited
